PALLAVI REDDY MUDDASANI BHASYAM: Open Payments
NPI 1902503261 · LAPEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 13 payments from 9 companies in 2025. Trend: 2023 $138 · 2024 $223 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Ozempic, TRELEGY ELLIPTA, COSENTYX, FREESTYLE LIBRE 3, Kerendia, MOUNJARO, Wegovy, Veozah.
Industry payments across IN — which companies pay providers there.
